(Helmholtz Association of German Research Centres) For the first time in more than 80 years a promising live vaccine against tuberculosis has passed into the clinical phase in Germany: Since Monday of this week the new vaccine, which goes by the designation "VPM1002", has begun safety testing on volunteers in a Phase I clinical trial in Neuss, Germany.
clinical phaseNovel tuberculosis vaccine in Germany in clinical phaseEurekAlert! - Chemistry, Physics and Materials Sciences Wed, 09/10/2008 - 22:00
|
